Terms: = Endocrine gland cancer AND WT1, WAGR, 7490, ENSG00000184937, WT33, GUD, WIT-2 AND Prognosis
52 results:
1. The management of uterine tumor resembling an ovarian sex cord tumor (UTROSCT): case series and literature review.
Lin J; Liu L; Wang L; Ma N; Zhang K; Xie N; Yu H; Deng S; Sun Y
World J Surg Oncol; 2024 Feb; 22(1):42. PubMed ID: 38310233
[TBL] [Abstract] [Full Text] [Related]
2. Identification of RAD51 foci in cancer-associated circulating cells of patients with high-grade serous ovarian cancer: association with treatment outcomes.
Alizzi Z; Saravi S; Khalique S; McDonald T; Karteris E; Hall M
Int J Gynecol Cancer; 2023 Sep; 33(9):1427-1433. PubMed ID: 37541687
[TBL] [Abstract] [Full Text] [Related]
3. A case of ovarian Teratoma with nephroblastoma presenting abdomen metastasis.
Wu Y; Chu C; Zhang J; Nitish B; Ni J; Xu X
J Clin Lab Anal; 2022 May; 36(5):e24364. PubMed ID: 35349728
[TBL] [Abstract] [Full Text] [Related]
4. Baseline immunity predicts prognosis of pancreatic cancer patients treated with wt1 and/or MUC1 peptide-loaded dendritic cell vaccination and a standard chemotherapy.
Ota S; Miyashita M; Yamagishi Y; Ogasawara M
Hum Vaccin Immunother; 2021 Dec; 17(12):5563-5572. PubMed ID: 34919493
[TBL] [Abstract] [Full Text] [Related]
5.
Deng J; Zhang J; Ye Y; Liu K; Zeng L; Huang J; Pan L; Li M; Bai R; Zhuang L; Huang X; Wu G; Wei L; Zheng Y; Su J; Zhang S; Chen R; Lin D; Zheng J
Cancer Res; 2021 Oct; 81(20):5268-5283. PubMed ID: 34362795
[TBL] [Abstract] [Full Text] [Related]
6. Dendritic cell vaccination combined with a conventional chemotherapy for patients with relapsed or advanced pancreatic ductal adenocarcinoma: a single-center phase I/II trial.
Ogasawara M; Miyashita M; Yamagishi Y; Ota S
Ther Apher Dial; 2021 Aug; 25(4):415-424. PubMed ID: 33886156
[TBL] [Abstract] [Full Text] [Related]
7. MicroRNA-216a targets wt1 expression and regulates KRT7 transcription to mediate the progression of pancreatic cancer-A transcriptome analysis.
Wang W; Wang J; Yang C; Wang J
IUBMB Life; 2021 Jun; 73(6):866-882. PubMed ID: 33759343
[TBL] [Abstract] [Full Text] [Related]
8. Wilms' tumor 1 (
Han Y; Song C; Zhang T; Zhou Q; Zhang X; Wang J; Xu B; Zhang X; Liu X; Ying X
Cell Cycle; 2020 Oct; 19(20):2662-2675. PubMed ID: 32892698
[TBL] [Abstract] [Full Text] [Related]
9. Desmoplastic Small Round Cell Tumor of Pancreatic Origin in a Young Child: A Case Report and Review of Literature.
Saleh D; Al-Maghrabi S; Al-Maghrabi H; Al-Maghrabi J
Am J Case Rep; 2020 Jul; 21():e922762. PubMed ID: 32655125
[TBL] [Abstract] [Full Text] [Related]
10. [Expression of ARID1A in ovarian seromucinous neoplasms and its clinicopathological significance].
Ding XH; Tian X; Wang LQ; Wang Y; Liu AJ
Zhonghua Bing Li Xue Za Zhi; 2020 Jun; 49(6):588-593. PubMed ID: 32486536
[No Abstract] [Full Text] [Related]
11. Establishment and characterization of a cell line and patient-derived xenograft (PDX) from peritoneal metastasis of low-grade serous ovarian carcinoma.
De Thaye E; Van de Vijver K; Van der Meulen J; Taminau J; Wagemans G; Denys H; Van Dorpe J; Berx G; Ceelen W; Van Bocxlaer J; De Wever O
Sci Rep; 2020 Apr; 10(1):6688. PubMed ID: 32317693
[TBL] [Abstract] [Full Text] [Related]
12. A 23-Year-Old Joradanian Woman with a Desmoplastic Small Round Cell Tumor Involving the Ovary.
Altal OF; Aleshawi AJ; Tashtush NA; Alhowary A
Am J Case Rep; 2019 Nov; 20():1675-1678. PubMed ID: 31723117
[TBL] [Abstract] [Full Text] [Related]
13. Clonal Evolution of
Garziera M; Cecchin E; Giorda G; Sorio R; Scalone S; De Mattia E; Roncato R; Gagno S; Poletto E; Romanato L; Ecca F; Canzonieri V; Toffoli G
Cells; 2019 Oct; 8(10):. PubMed ID: 31581548
[TBL] [Abstract] [Full Text] [Related]
14. The Frequency and Prognostic Significance of the Histologic Type in Early-stage Ovarian Carcinoma: A Reclassification Study by the Spanish Group for Ovarian cancer Research (GEICO).
Leskela S; Romero I; Cristobal E; Pérez-Mies B; Rosa-Rosa JM; Gutierrez-Pecharroman A; Santón A; Gonzalez BO; López-Reig R; Hardisson D; Vera-Sempere F; Illueca C; Vieites B; López-Guerrero JA; Palacios J; Poveda A
Am J Surg Pathol; 2020 Feb; 44(2):149-161. PubMed ID: 31498173
[TBL] [Abstract] [Full Text] [Related]
15. Quantitative proteomics identifies brain acid soluble protein 1 (BASP1) as a prognostic biomarker candidate in pancreatic cancer tissue.
Zhou Q; Andersson R; Hu D; Bauden M; Kristl T; Sasor A; Pawłowski K; Pla I; Hilmersson KS; Zhou M; Lu F; Marko-Varga G; Ansari D
EBioMedicine; 2019 May; 43():282-294. PubMed ID: 30982764
[TBL] [Abstract] [Full Text] [Related]
16. Proteomics-Derived Biomarker Panel Improves Diagnostic Precision to Classify Endometrioid and High-grade Serous Ovarian Carcinoma.
Dieters-Castator DZ; Rambau PF; Kelemen LE; Siegers GM; Lajoie GA; Postovit LM; Köbel M
Clin Cancer Res; 2019 Jul; 25(14):4309-4319. PubMed ID: 30979743
[TBL] [Abstract] [Full Text] [Related]
17. Breast metastasis two years after pelvic surgery and adjuvant chemotherapy for serous ovarian cancer.
Della Corte L; Giampaolino P; Fabozzi A; Cieri M; Zizolfi B; Morra I; Bifulco G
Gynecol Endocrinol; 2019 Mar; 35(3):211-213. PubMed ID: 30449229
[TBL] [Abstract] [Full Text] [Related]
18. Immunophenotypic profile as a predictor of prognosis in advanced ovarian carcinoma.
Yokoi A; Matsumoto T; Watanabe G; Tochimoto M; Saegusa M
Hum Pathol; 2019 Mar; 85():210-220. PubMed ID: 30448218
[TBL] [Abstract] [Full Text] [Related]
19. Ovarian Clear Cell Carcinoma Detected During Long-Term Management of Endometriotic Cysts in Young Patients: Possible Heterogeneity of this Tumor.
Komiyama S; Nagashima M; Taniguchi T; Yokouchi Y; Kugimiya T
Gynecol Obstet Invest; 2019; 84(3):305-312. PubMed ID: 30423566
[TBL] [Abstract] [Full Text] [Related]
20. High levels of serum glypican-1 indicate poor prognosis in pancreatic ductal adenocarcinoma.
Zhou CY; Dong YP; Sun X; Sui X; Zhu H; Zhao YQ; Zhang YY; Mason C; Zhu Q; Han SX
Cancer Med; 2018 Nov; 7(11):5525-5533. PubMed ID: 30358133
[TBL] [Abstract] [Full Text] [Related]
[Next]
